Mark Johnson | Senior Director of IR |
Dr. Sanjay Shukla | President & CEO |
Dr. David King | Chief Scientific Officer |
Matt Luchini | BMO Capital |
Katherine Xu | William Blair |
Ted Tenthoff | Piper Jaffray |
Carmen Ng | JPMorgan |
Joel Beatty | Citi |
Good morning, ladies and gentlemen, and welcome to the aTyr Pharma First Quarter 2018 Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder to our audience, this conference is being recorded for replay purposes. It is now my pleasure to hand the conference over to Mark Johnson, Senior Director of Investor Relations.